elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38979283-43B82099-EA02-4F48-8BF8-31D3F38AB17B
Q38979283-43B82099-EA02-4F48-8BF8-31D3F38AB17B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38979283-43B82099-EA02-4F48-8BF8-31D3F38AB17B
Clinical Pharmacokinetics and Pharmacodynamics of Cabozantinib.
P2860
Q38979283-43B82099-EA02-4F48-8BF8-31D3F38AB17B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38979283-43B82099-EA02-4F48-8BF8-31D3F38AB17B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7e05fe78ada3708986ec7f456d45b979ecea8b06
P2860
In vitro and in vivo activity of cabozantinib (XL184), an inhibitor of RET, MET, and VEGFR2, in a model of medullary thyroid cancer.